+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Antimicrobial Susceptibility Testing Market Size, Share & Industry Trends Analysis Report by Application, Method, Type, End User, Product, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 127 Pages
  • March 2023
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5779082
The Latin America, Middle East and Africa Antimicrobial Susceptibility Testing Market should witness market growth of 9.5% CAGR during the forecast period (2022-2028).

Antibacterial medications have a crucial role in preventing infectious diseases; nonetheless, drug abuse and overuse have contributed to the emergence of antibiotic resistance. Furthermore, it is difficult to limit the spread of infectious diseases when there is a delay in detecting hazardous bacteria. This places pressure on the key actors to produce accurate and effective test kits to treat patients more effectively.

AST also aids in the discovery of new antimicrobial medications by determining the susceptibility of existing or newly developed antimicrobial treatments against infection-causing microbes. While AST is a significant tool, it should not be the only consideration considered when establishing the optimal treatment approach for a patient. When picking the most appropriate antibiotic, examining the patient's allergies, kidney function, other medications, and general condition is necessary. AMR is a developing problem caused by microorganisms like bacteria, fungi, viruses, and parasites that have gained the ability to withstand the effects of medications such as antivirals, antibiotics, and antifungals.

In the United Arab Emirates (UAE), the national action plan (NAP) on antimicrobial resistance (AMR) was developed to explain the current national responses to AMR in the sectors of environmental protection,food safety, and human &animal health. In addition, technical subcommittees led the development and implementation of strategies and actions in certain domains, such as antimicrobial stewardship programs (ASP), surveillance, antimicrobial resistance (AMR) prevention & control, and infection prevention &control (IPC). These activities will be conducted along with other relevant ministries, authorities, organizations, research institutes, and comparison laboratories. As a result, AMR testing is gaining speed in the region, fueling the expansion of the antimicrobial resistance diagnostic market.

The Brazil market dominated the LAMEA Antimicrobial Susceptibility Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $88.8 million by 2028. The Argentina market is experiencing a CAGR of 10% during (2022-2028). Additionally, The UAE market would display a CAGR of 9.2% during (2022-2028).

Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Epidemiology & Others. Based on Method, the market is segmented into Automated Susceptibility Testing Instruments, Disk Diffusion, Etest Method, Agar Diffusion, and Genotyping Method. Based on Type, the market is segmented into Antibacterial, Antifungal, Antiparasitic, and Others. Based on End-user, the market is segmented into Hospitals & Diagnostic centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations. Based on Product, the market is segmented into Automated Laboratory Instruments, Manual Laboratory Instruments, Culture & Growth Media and Consumables. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMérieux S.A., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Accelerate Diagnostics, Inc., HiMedia Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.

Scope of the Study

By Application

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Epidemiology & Others

By Method

  • Automated Susceptibility Testing Instruments
  • Disk Diffusion
  • Etest Method
  • Agar Diffusion
  • Genotyping Method

By Type

  • Antibacterial
  • Antifungal
  • Antiparasitic
  • Others

By End-user

  • Hospitals & Diagnostic centers
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Clinical Research Organizations

By Product

  • Automated Laboratory Instruments
  • Manual Laboratory Instruments
  • Culture & Growth Media
  • Consumables

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • BioMérieux S.A.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Bruker Corporation
  • Accelerate Diagnostics, Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • F. Hoffmann-La Roche Ltd.

Unique Offerings

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Antimicrobial Susceptibility Testing Market, by Application
1.4.2 LAMEA Antimicrobial Susceptibility Testing Market, by Method
1.4.3 LAMEA Antimicrobial Susceptibility Testing Market, by Type
1.4.4 LAMEA Antimicrobial Susceptibility Testing Market, by End-user
1.4.5 LAMEA Antimicrobial Susceptibility Testing Market, by Product
1.4.6 LAMEA Antimicrobial Susceptibility Testing Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition &Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Antimicrobial Susceptibility Testing Market
Chapter 4. LAMEA Antimicrobial Susceptibility Testing Market by Application
4.1 LAMEA Clinical Diagnostics Market by Country
4.2 LAMEA Drug Discovery & Development Market by Country
4.3 LAMEA Epidemiology & Others Market by Country
Chapter 5. LAMEA Antimicrobial Susceptibility Testing Market by Method
5.1 LAMEA Automated Susceptibility Testing Instruments Market by Country
5.2 LAMEA Disk Diffusion Market by Country
5.3 LAMEA Etest Method Market by Country
5.4 LAMEA Agar Diffusion Market by Country
5.5 LAMEA Genotyping Method Market by Country
Chapter 6. LAMEA Antimicrobial Susceptibility Testing Market by Type
6.1 LAMEA Antibacterial Market by Country
6.2 LAMEA Antifungal Market by Country
6.3 LAMEA Antiparasitic Market by Country
6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Antimicrobial Susceptibility Testing Market by End-user
7.1 LAMEA Hospitals & Diagnostic centers Market by Country
7.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
7.3 LAMEA Research & Academic Institutes Market by Country
7.4 LAMEA Clinical Research Organizations Market by Country
Chapter 8. LAMEA Antimicrobial Susceptibility Testing Market by Product
8.1 LAMEA Automated Laboratory Instruments Market by Country
8.2 LAMEA Manual Laboratory Instruments Market by Country
8.3 LAMEA Culture & Growth Media Market by Country
8.4 LAMEA Consumables Market by Country
Chapter 9. LAMEA Antimicrobial Susceptibility Testing Market by Country
9.1 Brazil Antimicrobial Susceptibility Testing Market
9.1.1 Brazil Antimicrobial Susceptibility Testing Market by Application
9.1.2 Brazil Antimicrobial Susceptibility Testing Market by Method
9.1.3 Brazil Antimicrobial Susceptibility Testing Market by Type
9.1.4 Brazil Antimicrobial Susceptibility Testing Market by End-user
9.1.5 Brazil Antimicrobial Susceptibility Testing Market by Product
9.2 Argentina Antimicrobial Susceptibility Testing Market
9.2.1 Argentina Antimicrobial Susceptibility Testing Market by Application
9.2.2 Argentina Antimicrobial Susceptibility Testing Market by Method
9.2.3 Argentina Antimicrobial Susceptibility Testing Market by Type
9.2.4 Argentina Antimicrobial Susceptibility Testing Market by End-user
9.2.5 Argentina Antimicrobial Susceptibility Testing Market by Product
9.3 UAE Antimicrobial Susceptibility Testing Market
9.3.1 UAE Antimicrobial Susceptibility Testing Market by Application
9.3.2 UAE Antimicrobial Susceptibility Testing Market by Method
9.3.3 UAE Antimicrobial Susceptibility Testing Market by Type
9.3.4 UAE Antimicrobial Susceptibility Testing Market by End-user
9.3.5 UAE Antimicrobial Susceptibility Testing Market by Product
9.4 Saudi Arabia Antimicrobial Susceptibility Testing Market
9.4.1 Saudi Arabia Antimicrobial Susceptibility Testing Market by Application
9.4.2 Saudi Arabia Antimicrobial Susceptibility Testing Market by Method
9.4.3 Saudi Arabia Antimicrobial Susceptibility Testing Market by Type
9.4.4 Saudi Arabia Antimicrobial Susceptibility Testing Market by End-user
9.4.5 Saudi Arabia Antimicrobial Susceptibility Testing Market by Product
9.5 South Africa Antimicrobial Susceptibility Testing Market
9.5.1 South Africa Antimicrobial Susceptibility Testing Market by Application
9.5.2 South Africa Antimicrobial Susceptibility Testing Market by Method
9.5.3 South Africa Antimicrobial Susceptibility Testing Market by Type
9.5.4 South Africa Antimicrobial Susceptibility Testing Market by End-user
9.5.5 South Africa Antimicrobial Susceptibility Testing Market by Product
9.6 Nigeria Antimicrobial Susceptibility Testing Market
9.6.1 Nigeria Antimicrobial Susceptibility Testing Market by Application
9.6.2 Nigeria Antimicrobial Susceptibility Testing Market by Method
9.6.3 Nigeria Antimicrobial Susceptibility Testing Market by Type
9.6.4 Nigeria Antimicrobial Susceptibility Testing Market by End-user
9.6.5 Nigeria Antimicrobial Susceptibility Testing Market by Product
9.7 Rest of LAMEA Antimicrobial Susceptibility Testing Market
9.7.1 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Application
9.7.2 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Method
9.7.3 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Type
9.7.4 Rest of LAMEA Antimicrobial Susceptibility Testing Market by End-user
9.7.5 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Product
Chapter 10. Company Profiles
10.1 Bruker Corporation
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Product Launches and Product Expansions
10.1.5.2 Acquisition and Mergers
10.2 BioMérieux S.A.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent Strategies and Developments
10.2.5.1 Acquisition and Mergers
10.2.5.2 Approvals and Trials
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent Strategies and Developments
10.3.5.1 Partnerships, Collaborations, and Agreements
10.4 Accelerate Diagnostics, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent Strategies and Developments
10.4.5.1 Product Launches and Product Expansions
10.4.5.2 Approvals and Trials
10.5 Thermo Fisher Scientific, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions
10.6 Danaher Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.7 Bio-Rad laboratories, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 Recent Strategies and Developments
10.7.5.1 Acquisition and Mergers
10.8 Merck KGaA
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 F. Hoffmann-La Roche Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.10. HiMedia Laboratories Pvt. Ltd.
10.10.1 Company Overview
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Antimicrobial Susceptibility Testing Market, by Application
1.4.2 LAMEA Antimicrobial Susceptibility Testing Market, by Method
1.4.3 LAMEA Antimicrobial Susceptibility Testing Market, by Type
1.4.4 LAMEA Antimicrobial Susceptibility Testing Market, by End-user
1.4.5 LAMEA Antimicrobial Susceptibility Testing Market, by Product
1.4.6 LAMEA Antimicrobial Susceptibility Testing Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition &Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Antimicrobial Susceptibility Testing Market
Chapter 4. LAMEA Antimicrobial Susceptibility Testing Market by Application
4.1 LAMEA Clinical Diagnostics Market by Country
4.2 LAMEA Drug Discovery & Development Market by Country
4.3 LAMEA Epidemiology & Others Market by Country
Chapter 5. LAMEA Antimicrobial Susceptibility Testing Market by Method
5.1 LAMEA Automated Susceptibility Testing Instruments Market by Country
5.2 LAMEA Disk Diffusion Market by Country
5.3 LAMEA Etest Method Market by Country
5.4 LAMEA Agar Diffusion Market by Country
5.5 LAMEA Genotyping Method Market by Country
Chapter 6. LAMEA Antimicrobial Susceptibility Testing Market by Type
6.1 LAMEA Antibacterial Market by Country
6.2 LAMEA Antifungal Market by Country
6.3 LAMEA Antiparasitic Market by Country
6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Antimicrobial Susceptibility Testing Market by End-user
7.1 LAMEA Hospitals & Diagnostic centers Market by Country
7.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
7.3 LAMEA Research & Academic Institutes Market by Country
7.4 LAMEA Clinical Research Organizations Market by Country
Chapter 8. LAMEA Antimicrobial Susceptibility Testing Market by Product
8.1 LAMEA Automated Laboratory Instruments Market by Country
8.2 LAMEA Manual Laboratory Instruments Market by Country
8.3 LAMEA Culture & Growth Media Market by Country
8.4 LAMEA Consumables Market by Country
Chapter 9. LAMEA Antimicrobial Susceptibility Testing Market by Country
9.1 Brazil Antimicrobial Susceptibility Testing Market
9.1.1 Brazil Antimicrobial Susceptibility Testing Market by Application
9.1.2 Brazil Antimicrobial Susceptibility Testing Market by Method
9.1.3 Brazil Antimicrobial Susceptibility Testing Market by Type
9.1.4 Brazil Antimicrobial Susceptibility Testing Market by End-user
9.1.5 Brazil Antimicrobial Susceptibility Testing Market by Product
9.2 Argentina Antimicrobial Susceptibility Testing Market
9.2.1 Argentina Antimicrobial Susceptibility Testing Market by Application
9.2.2 Argentina Antimicrobial Susceptibility Testing Market by Method
9.2.3 Argentina Antimicrobial Susceptibility Testing Market by Type
9.2.4 Argentina Antimicrobial Susceptibility Testing Market by End-user
9.2.5 Argentina Antimicrobial Susceptibility Testing Market by Product
9.3 UAE Antimicrobial Susceptibility Testing Market
9.3.1 UAE Antimicrobial Susceptibility Testing Market by Application
9.3.2 UAE Antimicrobial Susceptibility Testing Market by Method
9.3.3 UAE Antimicrobial Susceptibility Testing Market by Type
9.3.4 UAE Antimicrobial Susceptibility Testing Market by End-user
9.3.5 UAE Antimicrobial Susceptibility Testing Market by Product
9.4 Saudi Arabia Antimicrobial Susceptibility Testing Market
9.4.1 Saudi Arabia Antimicrobial Susceptibility Testing Market by Application
9.4.2 Saudi Arabia Antimicrobial Susceptibility Testing Market by Method
9.4.3 Saudi Arabia Antimicrobial Susceptibility Testing Market by Type
9.4.4 Saudi Arabia Antimicrobial Susceptibility Testing Market by End-user
9.4.5 Saudi Arabia Antimicrobial Susceptibility Testing Market by Product
9.5 South Africa Antimicrobial Susceptibility Testing Market
9.5.1 South Africa Antimicrobial Susceptibility Testing Market by Application
9.5.2 South Africa Antimicrobial Susceptibility Testing Market by Method
9.5.3 South Africa Antimicrobial Susceptibility Testing Market by Type
9.5.4 South Africa Antimicrobial Susceptibility Testing Market by End-user
9.5.5 South Africa Antimicrobial Susceptibility Testing Market by Product
9.6 Nigeria Antimicrobial Susceptibility Testing Market
9.6.1 Nigeria Antimicrobial Susceptibility Testing Market by Application
9.6.2 Nigeria Antimicrobial Susceptibility Testing Market by Method
9.6.3 Nigeria Antimicrobial Susceptibility Testing Market by Type
9.6.4 Nigeria Antimicrobial Susceptibility Testing Market by End-user
9.6.5 Nigeria Antimicrobial Susceptibility Testing Market by Product
9.7 Rest of LAMEA Antimicrobial Susceptibility Testing Market
9.7.1 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Application
9.7.2 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Method
9.7.3 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Type
9.7.4 Rest of LAMEA Antimicrobial Susceptibility Testing Market by End-user
9.7.5 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Product
Chapter 10. Company Profiles
10.1 Bruker Corporation
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Product Launches and Product Expansions
10.1.5.2 Acquisition and Mergers
10.2 BioMérieux S.A.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent Strategies and Developments
10.2.5.1 Acquisition and Mergers
10.2.5.2 Approvals and Trials
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent Strategies and Developments
10.3.5.1 Partnerships, Collaborations, and Agreements
10.4 Accelerate Diagnostics, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent Strategies and Developments
10.4.5.1 Product Launches and Product Expansions
10.4.5.2 Approvals and Trials
10.5 Thermo Fisher Scientific, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions
10.6 Danaher Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.7 Bio-Rad laboratories, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 Recent Strategies and Developments
10.7.5.1 Acquisition and Mergers
10.8 Merck KGaA
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 F. Hoffmann-La Roche Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.10. HiMedia Laboratories Pvt. Ltd.
10.10.1 Company Overview
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Antimicrobial Susceptibility Testing Market, by Application
1.4.2 LAMEA Antimicrobial Susceptibility Testing Market, by Method
1.4.3 LAMEA Antimicrobial Susceptibility Testing Market, by Type
1.4.4 LAMEA Antimicrobial Susceptibility Testing Market, by End-user
1.4.5 LAMEA Antimicrobial Susceptibility Testing Market, by Product
1.4.6 LAMEA Antimicrobial Susceptibility Testing Market, by Country
1.5 Research Methodology
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition &Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Antimicrobial Susceptibility Testing Market
Chapter 4. LAMEA Antimicrobial Susceptibility Testing Market by Application
4.1 LAMEA Clinical Diagnostics Market by Country
4.2 LAMEA Drug Discovery & Development Market by Country
4.3 LAMEA Epidemiology & Others Market by Country
Chapter 5. LAMEA Antimicrobial Susceptibility Testing Market by Method
5.1 LAMEA Automated Susceptibility Testing Instruments Market by Country
5.2 LAMEA Disk Diffusion Market by Country
5.3 LAMEA Etest Method Market by Country
5.4 LAMEA Agar Diffusion Market by Country
5.5 LAMEA Genotyping Method Market by Country
Chapter 6. LAMEA Antimicrobial Susceptibility Testing Market by Type
6.1 LAMEA Antibacterial Market by Country
6.2 LAMEA Antifungal Market by Country
6.3 LAMEA Antiparasitic Market by Country
6.4 LAMEA Others Market by Country
Chapter 7. LAMEA Antimicrobial Susceptibility Testing Market by End-user
7.1 LAMEA Hospitals & Diagnostic centers Market by Country
7.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
7.3 LAMEA Research & Academic Institutes Market by Country
7.4 LAMEA Clinical Research Organizations Market by Country
Chapter 8. LAMEA Antimicrobial Susceptibility Testing Market by Product
8.1 LAMEA Automated Laboratory Instruments Market by Country
8.2 LAMEA Manual Laboratory Instruments Market by Country
8.3 LAMEA Culture & Growth Media Market by Country
8.4 LAMEA Consumables Market by Country
Chapter 9. LAMEA Antimicrobial Susceptibility Testing Market by Country
9.1 Brazil Antimicrobial Susceptibility Testing Market
9.1.1 Brazil Antimicrobial Susceptibility Testing Market by Application
9.1.2 Brazil Antimicrobial Susceptibility Testing Market by Method
9.1.3 Brazil Antimicrobial Susceptibility Testing Market by Type
9.1.4 Brazil Antimicrobial Susceptibility Testing Market by End-user
9.1.5 Brazil Antimicrobial Susceptibility Testing Market by Product
9.2 Argentina Antimicrobial Susceptibility Testing Market
9.2.1 Argentina Antimicrobial Susceptibility Testing Market by Application
9.2.2 Argentina Antimicrobial Susceptibility Testing Market by Method
9.2.3 Argentina Antimicrobial Susceptibility Testing Market by Type
9.2.4 Argentina Antimicrobial Susceptibility Testing Market by End-user
9.2.5 Argentina Antimicrobial Susceptibility Testing Market by Product
9.3 UAE Antimicrobial Susceptibility Testing Market
9.3.1 UAE Antimicrobial Susceptibility Testing Market by Application
9.3.2 UAE Antimicrobial Susceptibility Testing Market by Method
9.3.3 UAE Antimicrobial Susceptibility Testing Market by Type
9.3.4 UAE Antimicrobial Susceptibility Testing Market by End-user
9.3.5 UAE Antimicrobial Susceptibility Testing Market by Product
9.4 Saudi Arabia Antimicrobial Susceptibility Testing Market
9.4.1 Saudi Arabia Antimicrobial Susceptibility Testing Market by Application
9.4.2 Saudi Arabia Antimicrobial Susceptibility Testing Market by Method
9.4.3 Saudi Arabia Antimicrobial Susceptibility Testing Market by Type
9.4.4 Saudi Arabia Antimicrobial Susceptibility Testing Market by End-user
9.4.5 Saudi Arabia Antimicrobial Susceptibility Testing Market by Product
9.5 South Africa Antimicrobial Susceptibility Testing Market
9.5.1 South Africa Antimicrobial Susceptibility Testing Market by Application
9.5.2 South Africa Antimicrobial Susceptibility Testing Market by Method
9.5.3 South Africa Antimicrobial Susceptibility Testing Market by Type
9.5.4 South Africa Antimicrobial Susceptibility Testing Market by End-user
9.5.5 South Africa Antimicrobial Susceptibility Testing Market by Product
9.6 Nigeria Antimicrobial Susceptibility Testing Market
9.6.1 Nigeria Antimicrobial Susceptibility Testing Market by Application
9.6.2 Nigeria Antimicrobial Susceptibility Testing Market by Method
9.6.3 Nigeria Antimicrobial Susceptibility Testing Market by Type
9.6.4 Nigeria Antimicrobial Susceptibility Testing Market by End-user
9.6.5 Nigeria Antimicrobial Susceptibility Testing Market by Product
9.7 Rest of LAMEA Antimicrobial Susceptibility Testing Market
9.7.1 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Application
9.7.2 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Method
9.7.3 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Type
9.7.4 Rest of LAMEA Antimicrobial Susceptibility Testing Market by End-user
9.7.5 Rest of LAMEA Antimicrobial Susceptibility Testing Market by Product
Chapter 10. Company Profiles
10.1 Bruker Corporation
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent Strategies and Developments
10.1.5.1 Product Launches and Product Expansions
10.1.5.2 Acquisition and Mergers
10.2 BioMérieux S.A.
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expenses
10.2.5 Recent Strategies and Developments
10.2.5.1 Acquisition and Mergers
10.2.5.2 Approvals and Trials
10.3 Becton, Dickinson and Company
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent Strategies and Developments
10.3.5.1 Partnerships, Collaborations, and Agreements
10.4 Accelerate Diagnostics, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Regional Analysis
10.4.4 Research & Development Expenses
10.4.5 Recent Strategies and Developments
10.4.5.1 Product Launches and Product Expansions
10.4.5.2 Approvals and Trials
10.5 Thermo Fisher Scientific, Inc.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expenses
10.5.5 Recent Strategies and Developments
10.5.5.1 Product Launches and Product Expansions
10.6 Danaher Corporation
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.7 Bio-Rad laboratories, Inc.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Segmental and Regional Analysis
10.7.4 Research & Development Expenses
10.7.5 Recent Strategies and Developments
10.7.5.1 Acquisition and Mergers
10.8 Merck KGaA
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expense
10.9 F. Hoffmann-La Roche Ltd.
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.10. HiMedia Laboratories Pvt. Ltd.
10.10.1 Company Overview

Companies Mentioned

  • BioMérieux S.A.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Bruker Corporation
  • Accelerate Diagnostics, Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • F. Hoffmann-La Roche Ltd.

Methodology

Loading
LOADING...